BEDFORD, Mass., March 6, 2014 /PRNewswire/ -- Hologic, Inc.
(Hologic or the Company) (NASDAQ: HOLX), a leading developer,
manufacturer and supplier of premium diagnostic products, medical
imaging systems and surgical products with an emphasis on serving
the healthcare needs of women, announced today that the American
Medical Association (AMA) CPT Editorial Panel posted its Summary of
Panel Actions from the February, 2014 Panel Meeting.
According to the Summary of Panel Actions, the application
submitted for breast tomosynthesis was accepted for three Category
I CPT codes that include screening and diagnostic breast
tomosynthesis.
The Summary of Panel Actions is a preliminary step and codes are
not assigned, nor is exact wording finalized, until just prior to
the publication of the CPT Professional Edition 2015. The Medicare
payment rates associated with the breast tomosynthesis codes will
not be posted until the Medicare Physician Fee Schedule Final Rule
is issued by the Centers for Medicare & Medicaid Services (CMS)
on or around November 1, 2014. The
CPT codes and rates are scheduled for implementation January 1, 2015. For additional information,
please refer to the Summary of Panel Actions available on the AMA
website.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems, and
surgical products, with an emphasis on serving the healthcare needs
of women. The Company operates four core business units focused on
breast health, diagnostics, GYN surgical and skeletal health. With
a comprehensive suite of technologies and a robust research and
development program, Hologic is committed to improving lives. The
Company is headquartered in Massachusetts. For more information, visit
www.hologic.com.
Hologic and associated logos are trademarks and/or registered
trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.
CPT is a registered trademark of the American Medical
Association.
|
Investor Relations
and Media Contacts:
|
|
|
Deborah R.
Gordon
|
|
|
|
Al Kildani
|
|
Vice President,
Investor Relations
|
|
|
|
Senior Director,
Investor Relations
|
|
(781)
999-7716
|
|
|
|
(858)
410-8653
|
|
deborah.gordon@hologic.com
|
|
|
|
al.kildani@hologic.com
|
SOURCE Hologic, Inc.